Literature DB >> 10414438

Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.

S Izenwasser1, A E Coy, B Ladenheim, R J Loeloff, J L Cadet, D French.   

Abstract

Continuous infusion of cocaine produces partial behavioral tolerance to its locomotor activating effects, while daily injections produce sensitization. Methylphenidate binds with a similar affinity to cocaine at the dopamine transporter, but has a much lower affinity for the serotonin transporter than does cocaine. This study was done to compare the effects of chronic methylphenidate with chronic cocaine. The pattern of locomotor activity over a 7 day treatment period was significantly different from cocaine. Methylphenidate elevated activity on each day, compared to saline, yet neither tolerance to a continuous infusion of the drug, nor sensitization to repeated daily injections was produced. We have previously shown that neither of these treatments with cocaine produces significant alterations in dopamine transporter density 1 day after the end of treatment. In contrast, methylphenidate injections significantly decreased dopamine transporters in rostral caudate putamen, with no change in nucleus accumbens. Continuous infusion of methylphenidate had no effect on dopamine transporters in either brain region. These findings provide further evidence that different classes of dopamine uptake inhibitors may interact with the dopamine transporter in qualitatively different manners. Furthermore, it is possible that the inhibition of serotonin uptake by cocaine may contribute to the adaptations in behavioral activity that are seen during chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414438     DOI: 10.1016/s0014-2999(99)00274-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Behavioral and neuronal recording of the nucleus accumbens in adolescent rats following acute and repetitive exposure to methylphenidate.

Authors:  Alexander Frolov; Cruz Reyes-Vasquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2014-10-15       Impact factor: 2.714

2.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

3.  Repeated administration of methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood.

Authors:  Annelyn Torres-Reverón; Diana L Dow-Edwards
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  Methylphenidate modulates the locus ceruleus neuronal activity in freely behaving rat.

Authors:  Bin Tang; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-09-18       Impact factor: 4.432

5.  Acute and chronic methylphenidate administration in intact and VTA-specific and nonspecific lesioned rats.

Authors:  Stephanie A Ihezie; Ming M Thomas; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2019-01-08       Impact factor: 3.575

6.  A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.

Authors:  Panayotis K Thanos; Lisa S Robison; Jessica Steier; Yu Fen Hwang; Thomas Cooper; James M Swanson; David E Komatsu; Michael Hadjiargyrou; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2015-01-29       Impact factor: 3.533

7.  No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats.

Authors:  R J J Knol; K de Bruin; B L F van Eck-Smit; J Booij
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-23       Impact factor: 9.236

8.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

9.  Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats.

Authors:  Emanuele Seu; J David Jentsch
Journal:  Neuropharmacology       Date:  2009-08-22       Impact factor: 5.250

10.  Juvenile methylphenidate exposure and factors that influence incentive processing.

Authors:  Heather C Brenhouse; Lee Napierata; Lucinda Kussmaul; Melanie Leussis; Susan L Andersen
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.